US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may ...

AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school ...

Viking Therapeutics has strong R&D, dual-track obesity drugs, and solid cash runway. Click here to read an analysis of VKTX ...

What Happened? Shares of animal health company Elanco (NYSE:ELAN) jumped 3% in the pre-market session after the company ...

The Fund’s more diversified and defensive exposure compared to our concentrated benchmark reversed from a tailwind in the ...

Eli Lilly's Alzheimer's drug, donanemab (Kisqali), just got a thumbs-up from the European Medicines Agency's (EMA) expert ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.